Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020

GlobalData, the industry analysis specialist, has released its new report, “Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020”. The report is an essential source of information and analysis on the global prostate cancer therapeutics market. The report provides detailed overview on various treatment options that are currently used in the treatment of prostate cancer. The report identifies the key trends shaping and driving the global prostate cancer therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global prostate cancer sector.

Scope

The scope of the report includes:

Detailed overview on the symptoms, diagnosis and treatment of prostate cancer.

Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France Japan and BRIC countries that include Brazil, Russia, India and China.

Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include EGFR inhibitors, VEGF inhibitors, tyrosine kinase inhibitor, angiogenesis inhibitors and others.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Checkpoint Inhibitors for Treating Cancer in these

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Anti-Cancer Injectable in these regions, from 2012

The global Specific Cancer Immunotherapy Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Asia-Pacific will occupy for more market share in following years, especially in China, also f

Popular Reports

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Zika Virus market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’

Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Cervical Cancer Vaccine in these regions, from 2012 to 2022 (forecast). Unite